We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TA
2376
DELISTED
TravelCenters of America LLC
TA
| $727K | ﹤0.01% |
14,611
+2,006
| +16% | +$75.1K |
|
|
ITOS
2377
DELISTED
iTeos Therapeutics
ITOS
| $723K | ﹤0.01% |
26,770
+610
| +2% | +$15.9K |
|
2378
Vera Bradley
VRA
$98.7M
| $723K | ﹤0.01% |
76,782
-256
| -0.3% | -$2.81K |
|
|
REVG
2379
DELISTED
REV Group
REVG
| $722K | ﹤0.01% |
42,070
+729
| +2% | +$11.6K |
|
|
AFMD
2380
DELISTED
Affimed
AFMD
| $719K | ﹤0.01% |
11,640
+484
| +4% | +$31.9K |
|
|
CFB
2381
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $719K | ﹤0.01% |
55,313
+1,631
| +3% | +$21.6K |
|
|
DSEY
2382
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $717K | ﹤0.01% |
44,729
+3,358
| +8% | +$55.6K |
|
|
DFTX
2383
Definium Therapeutics
DFTX
$6.12B
| $716K | ﹤0.01% |
20,480
+992
| +5% | +$42.9K |
|
2384
Arrow Financial
AROW
$652M
| $715K | ﹤0.01% |
22,078
+682
| +3% | +$22.4K |
|
2385
York Water
YORW
$514M
| $715K | ﹤0.01% |
16,366
+285
| +2% | +$13.7K |
|
|
DX
2386
Dynex Capital
DX
$3.21B
| $714K | ﹤0.01% |
41,345
+3,016
| +8% | +$53.3K |
|
2387
Annexon
ANNX
$886M
| $712K | ﹤0.01% |
38,281
+1,475
| +4% | +$29.9K |
|
2388
Inseego
INSG
$90.5M
| $712K | ﹤0.01% |
10,684
+341
| +3% | +$28.5K |
|
|
PRTY
2389
DELISTED
Party City Holdco Inc.
PRTY
| $708K | ﹤0.01% |
99,763
+4,611
| +5% | +$35.1K |
|
|
GAN
2390
DELISTED
GAN Ltd
GAN
| $707K | ﹤0.01% |
47,566
+1,875
| +4% | +$30K |
|
|
ORC
2391
Orchid Island Capital
ORC
$1.31B
| $707K | ﹤0.01% |
28,930
+5,304
| +22% | +$134K |
|
|
KLRS
2392
Kalaris Therapeutics
KLRS
$96.8M
| $707K | ﹤0.01% |
1,226
+57
| +5% | +$26.4K |
|
2393
MiMedx Group
MDXG
$633M
| $703K | ﹤0.01% |
116,035
+5,852
| +5% | +$66K |
|
2394
Cullinan Oncology
CGEM
$1.14B
| $700K | ﹤0.01% |
31,025
+15,998
| +106% | +$428K |
|
2395
VSE Corp
VSEC
$6.12B
| $700K | ﹤0.01% |
14,528
+500
| +4% | +$24.3K |
|
|
RVI
2396
DELISTED
Retail Value Inc. Common Shares
RVI
| $700K | ﹤0.01% |
289,541
+7,387
| +3% | +$16.8K |
|
2397
Turning Point Brands
TPB
$1.74B
| $699K | ﹤0.01% |
14,647
+1,078
| +8% | +$51.7K |
|
2398
Lifestance Health
LFST
$4.14B
| $696K | ﹤0.01% |
+48,019
| New | +$925K |
|
2399
Standard BioTools
LAB
$314M
| $695K | ﹤0.01% |
105,527
+2,435
| +2% | +$16K |
|
2400
Curis
CRIS
$7.83M
| $693K | ﹤0.01% |
221
+13
| +6% | +$40.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.